Informa’s (INF) Buy Rating Reiterated at Berenberg Bank

Berenberg Bank restated their buy rating on shares of Informa (LON:INF) in a research report released on Thursday morning, Marketbeat reports. They currently have a GBX 1,040 target price on the stock.

Several other research analysts have also weighed in on INF. Citigroup upped their price target on Informa from GBX 990 to GBX 1,090 and gave the company a “buy” rating in a research report on Wednesday, August 12th. JPMorgan Chase & Co. decreased their price objective on Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating for the company in a research report on Thursday, July 2nd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 1,140 target price on shares of Informa in a research note on Friday, July 31st. Six equities research analysts have rated the stock with a Buy rating. According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of GBX 1,160.

Informa Stock Performance

Shares of INF opened at GBX 895.60 on Thursday. Informa has a one year low of GBX 719 and a one year high of GBX 1,000. The company has a 50-day moving average of GBX 893.22 and a two-hundred day moving average of GBX 853.04. The stock has a market cap of £11.19 billion, a price-to-earnings ratio of 52.37, a PEG ratio of 0.75 and a beta of 0.71. The company has a debt-to-equity ratio of 64.99, a current ratio of 0.55 and a quick ratio of 1.70.

Informa (LON:INF) last released its quarterly earnings results on Thursday, July 30th. The company reported GBX 26.70 earnings per share (EPS) for the quarter. Informa had a net margin of 5.43% and a return on equity of 3.90%. On average, equities research analysts expect that Informa will post 59.32 earnings per share for the current year.

Informa Company Profile

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.